
|Articles|February 1, 2002
Congress fails to restore Medicare reimbursement cuts
Patients' rights, regulatory reform, and research funding are still underconsiderationWashington-With a 5.5% decrease in Medicare reimbursement rates now inplace for 2002, urologists and other specialty groups are hoping to convinceCongress to quickly reduce those cuts and act on other issues importantto them, as well.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5











